RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
Clinical trial NCT03189914 · COMPLETED
Trial details
- NCT number
- NCT03189914
- Sponsor
- Processa Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-02
- Primary completion
- 2019-10-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.